【目的】 探讨新辅助化疗对Ⅰb2 ~ Ⅲb期宫颈癌的近期临床疗效? 【方法】 选择我院2003年6月~2007年9月收治的经病理确诊的28例Ⅰb2 ~ Ⅲb期宫颈癌患者,动脉介入化疗18例,化疗方案:卡铂(300 mg/m2)+博来霉素(45 mg);静脉化疗10例,化疗方案:卡铂(AUC 6)+5*9鄄FU(4 000 mg/m2 > 96 h)?化疗10 ~ 14 d重新评估,化疗2 ~ 3周行广泛全子宫切除术+盆腔淋巴结清扫术,观察近期临床疗效?【结果】 化疗有效率82.1%(23/28 ...
温国群
core
[An auxiliary diagnosis system for cervical intraepithelial neoplasia based on colposcopic images]. [PDF]
Gu X +6 more
europepmc +1 more source
[Value of combined detection of claudin 4 and high-risk human papilloma virus in high-grade squamous intraepithelial lesion and cervix squamous cell carcinoma]. [PDF]
Di C, Jin F.
europepmc +1 more source
[TruScreen Combined With High-Risk Human Papillomavirus Testing vs Thinprep Cytology Test Combined With High-Risk Human Papillomavirus Testing for Cervical Cancer Screening: A Comparative Clinical Study]. [PDF]
Yang Y +5 more
europepmc +1 more source
[Uterine and ovarian relapse of acute lymphoblastic leukemia after transplantation: A case report]. [PDF]
Zang H, Fu H, Lei J, Yi S.
europepmc +1 more source
[Analysis of efficacy and prognosis of neoadjuvant chemotherapy and (or) surgery plus radiotherapy for hypopharyngeal squamous cell carcinoma]. [PDF]
Xiao Q +6 more
europepmc +1 more source
[CRISPR-Cas9-mediated CDC20 gene knockout inhibits cervical cancer cell proliferation, invasion and metastasis]. [PDF]
Mo Y +6 more
europepmc +1 more source
[Therapeutic mechanism of hederagenin, an active component in <i>Guizhi Fuling</i> Pellets, against cervical cancer in nude mice]. [PDF]
Zhu Y +6 more
europepmc +1 more source
【目的】研究耐放疗的宫颈癌Hela细胞生物学特性的改变,并探讨其与宫颈癌肿瘤干细胞间的关系。【方法】采用多次分割剂量照射技术建立宫颈癌Hela细胞的耐放疗模型(Hela-R),实验分4组:Hela-R1组,Hela-R2组,Hela-R3组和对照组。四甲基偶氮唑蓝法检测细胞生长情况,克隆形成实验测定放射敏感性和克隆能力,流式细胞术检测细胞周期分布和增殖能力,球囊培养法检测细胞自我更新能力。【结果】Hela、Hela-R细胞接受照射后均呈现先加速增殖后出现生长抑制的现象。Hela-R1、Hela-R2 ...
core

